MREO · Mereo BioPharma Group plc · Proposed Sales
Market Cap
$44.71M
Shares
159.69M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2024-09-12 | Fox Christine Ann | Officer | 28,286 | 2024-09-12 | Morgan Stanley & Co. LLC |
| 2024-09-12 | Alexandra Hughes-Wilson | Officer | 148,110 | 2024-09-12 | Morgan Stanley & Co. LLC |
| 2024-09-12 | Lewicki John A. | Officer | 16,149 | 2024-09-12 | Morgan Stanley & Co. LLC |
| 2024-09-12 | Scots-Knight Denise | Officer, Director | 88,657 | 2024-09-12 | Morgan Stanley & Co. LLC |
| 2024-09-12 | Sermon Charles | Officer | 30,926 | 2024-09-12 | Morgan Stanley & Co. LLC |
| 2024-08-22 | Deepika Pakianathan | Director | 105,244 | 2024-08-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-06-20 | Lewicki John A. | Officer | 26,647 | 2024-06-21 | Morgan Stanley International, plc |
| 2024-06-20 | Scots-Knight Denise | Officer, Director | 146,284 | 2024-06-21 | Morgan Stanley International, plc |
| 2024-06-20 | Sermon Charles | Officer | 51,028 | 2024-06-21 | Morgan Stanley International, plc |
| 2024-06-20 | Alexandra Hughes-Wilson | Officer | 33,102 | 2024-06-21 | Morgan Stanley International, plc |
| 2024-06-20 | Fox Christine Ann | Officer | 46,672 | 2024-06-21 | Morgan Stanley International, plc |
| 2024-05-23 | Alexandra Hughes-Wilson | Officer | 100,432 | 2024-05-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–12 of 12 filings
Key facts
CIK
1719714
CUSIP
589492107
13F (30d)
33 filings
33 filers
Visit website
Investor relations